Glibenclamide treatment in relapsed transient neonatal diabetes as a result of a KCNJ11 activating mutation (N48D).
Martín-Frías
M
M
Colino
E
E
Pérez de Nanclares
G
G
Alonso
M
M
Ros
P
P
Barrio
R
R
D002648:Child; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000235:genetics; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D012008:Recurrence
D007004:Hypoglycemic Agents; D005905:Glyburide